Access EIS investments for July 2022.

SyndicateRoom logo
Syndicate Room
8 August 20222 min read

In July, SyndicateRoom added two new startups to the Access EIS portfolio, investing alongside super angels in each case (for more on our super angels, and our co-investment model, see our dedicated page. Find out more about our fund, Access EIS, or read about our new portfolio companies below.


Toastie

Toastie aims to create a deeper connection between children and the environment, with a view to promoting positive mental health and wellbeing in future generations coupled with a lifelong desire to nurture and protect our planet.

Toastie

Our angel partner in the round has a flat average CAGR of 29% and has invested in Peanut, Zen Education, and Near St, to name a few.

Total Round: approx. £400,000.

Stage: Post-revenue.

Visit website


Thalamos

Thalamos joins up admission, treatment and discharge care pathways to improve patient outcomes in mental healthcare.

Thalamos

Our angel partner in the round has a weighted IRR of 126% and has invested in Adzuna, Tandem, and VouchedFor.

Total Round: approx. £400,000.

Stage: Post-revenue.

Visit website


Award
What is Access EIS?
Read our fund brochure for everything you need to know about Access, from the specifics of our innovative co-investment model to our fees, and how to invest.

Risk warning: Please click here to read the full risk warning.
Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.
This page has been approved as a financial promotion by Syndicate Room Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 613021).
We use cookies to improve our service. By continuing to use this site you are agreeing to their use. Find out more.
Please provide your email and/or phone number and we'll get back to you as soon as possible.
Access EIS investments for July 2022.